LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Bolden Therapeutics

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s disease and ischemic stroke. Bolden’s research facility is located in Cambridge, MA, and its corporate headquarters is located in Providence, RI.

  • Anne Valat Research Scientist